Entity
  • Orano Med

    Created in 2009
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    356 7,997 7,997
  • Activities

  • Technologies

  • Entity types

  • Location

    700 Klein Rd, Plano, TX 75074, USA

    Plano

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 147

  • Engaged corporates

    8
    2 8
  • Added in Motherbase

    3 years, 2 months ago
Description
  • Value proposition

    Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212)

    Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells.

    Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.

    Nuclear Medicine & Nuclear Industry, Biotechnology, Pharmaceutical, and Clinical Trial

  • Orano Med | Home

    Orano Med seeks to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb)

  • https://www.oranomed.com/en
Corporate interactions BETA
Corporate TypeTweets Articles
Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

28 Sep 2024


BFM Business
BFM Business
Media, Broadcast Media Production and Distribution
BFM Business
Media, Broadcast Media Production and Distribution
Other

27 Mar 2024


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

27 Mar 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

27 Mar 2024


Kurma Partners
Kurma Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Kurma Partners
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

19 Nov 2022


Région Nouvelle-Aquitaine
Région Nouvelle-Aquitaine
National and local authorities, Government Administration
Région Nouvelle-Aquitaine
National and local authorities, Government Administration
Other

5 Jul 2024


Hello Tomorrow
Hello Tomorrow
Trade show, Business Consulting and Services
Hello Tomorrow
Trade show, Business Consulting and Services
Other

7 Mar 2023


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Not capitalistic
Partnership
Not event

1 Jul 2015


Similar entities
Loading...
Loading...
Social network dynamics